Free tool
FAERS Monitor: Hyzaar
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020387 or its brand name (Hyzaar, Hydrochlorothiazide, Losartan Potassium). Reports on generic versions are filed under their own applications.
Reports
11,595
Serious
7,498
65% of reports
Hospitalization
4,037
Death reported
698
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- nausea773
- drug ineffective742
- fatigue692
- dizziness594
- headache563
- diarrhoea536
- pain515
- dyspnoea513
- arthralgia453
- asthenia451
- vomiting407
- hypertension380
- blood pressure increased361
- malaise351
- fall349
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 470 |
| 2005 | 589 |
| 2006 | 625 |
| 2007 | 621 |
| 2008 | 610 |
| 2009 | 677 |
| 2010 | 843 |
| 2011 | 766 |
| 2012 | 760 |
| 2013 | 445 |
| 2014 | 616 |
| 2015 | 652 |
| 2016 | 722 |
| 2017 | 493 |
| 2018 | 506 |
| 2019 | 568 |
| 2020 | 381 |
| 2021 | 233 |
| 2022 | 275 |
| 2023 | 190 |
| 2024 | 179 |
| 2025 | 229 |
| 2026 | 144 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,564 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| blood pressure increasedSignal | 361 | 4.3 | 3.9 | 912 |
| hypertensionSignal | 380 | 3.3 | 3.0 | 598 |
| astheniaSignal | 451 | 2.2 | 2.0 | 291 |
| dizzinessSignal | 594 | 2.2 | 2.0 | 378 |
| arthralgia | 453 | 2.0 | 1.8 | 222 |
| fall | 349 | 1.9 | 1.7 | 151 |
| nausea | 773 | 1.8 | 1.7 | 269 |
| dyspnoea | 513 | 1.6 | 1.5 | 132 |
| headache | 563 | 1.6 | 1.5 | 140 |
| fatigue | 692 | 1.6 | 1.5 | 167 |
| vomiting | 407 | 1.6 | 1.4 | 86 |
| pain | 515 | 1.5 | 1.4 | 94 |
| diarrhoea | 536 | 1.5 | 1.4 | 94 |
| malaise | 351 | 1.5 | 1.3 | 50 |
| drug ineffective | 742 | 1.0 | 1.0 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.